Table 2.
Summary of Patient Assessments
| Assessment | Screening/enrollment | 3 Months after randomization | 6 Months after randomization |
|---|---|---|---|
| Individual information | |||
| Demographics (sex/gender, age, race and ethnicity, marital status, SES, and insurance status) | X | ||
| Cardiovascular disease history (indication for CR, other cardiovascular comorbidities, and current use of guideline‐based cardiovascular medication therapies) | X | ||
| General health, medical history, health status, and preventive care | X | ||
| Cardiovascular health (LE8) measures | |||
| Diet quality | X | X | X |
| PA patterns | X | X | X |
| Nicotine exposure | X | X | X |
| Sleep quality | X | X | X |
| Body mass index | X | X | X |
| Blood lipids (non‐HDL) | X | X | X |
| Blood glucose/hemoglobin A1c | X | X | X |
| BP | X | X | X |
| Cardiovascular outcomes | |||
| MACE composite | X | X | |
| Functional capacity | |||
| 6‐Min walk distance | X | X | X |
| Psychosocial measures | |||
| Quality of life | X | X | X |
| Diet/PA self‐efficacy | X | X | X |
| Diet/PA self‐regulation | X | X | X |
| Diet/PA social support | X | X | X |
BP indicates blood pressure; CR, cardiac rehabilitation; HDL, high‐density lipoprotein; LE8, Life's Essential 8; MACE, major adverse cardiovascular event; PA, physical activity; and SES, socioeconomic status.